泛素
蛋白质降解
计算生物学
蛋白酶体
蛋白质组
胞浆
小分子
化学
生物
细胞生物学
生物化学
酶
基因
作者
Derek VanDyke,Jonathan D. Taylor,Kyle J. Kaeo,James Hunt,Jamie B. Spangler
标识
DOI:10.1016/j.copbio.2022.102807
摘要
Targeted protein degradation (TPD) is a broadly useful proteome editing tool for biological research and therapeutic development. TPD offers several advantages over functional inhibition alone, including the ability to target previously undruggable proteins and the substantial and sustained knockout of protein activity. A variety of small molecule approaches hijack endogenous protein degradation machinery, but are limited to proteins with a cytosolic domain and suitable binding pocket. Recently, biologics-based methods have expanded the TPD toolbox by allowing access to extracellular and surface-exposed proteins and increasing target specificity. Here, we summarize recent advances in the use of biologics to deplete proteins through either the ubiquitin-proteasome system or the lysosomal degradation pathway, and discuss routes to their effective delivery as potential therapeutic interventions.
科研通智能强力驱动
Strongly Powered by AbleSci AI